23 May 2013
Keywords: Bristol-Myers Squibb, Baraclude, Hepatitis B, USA, FDA
Article | 20 October 2010
The US Food and Drug Administration has approved drug major Bristol-Myers Squibb’s (NYSE: BMY) supplemental New Drug Application ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2010
22 May 2013
© 2013 thepharmaletter.com